European nations weigh impact of Brexit on drug supplies

Germany’s drug safety regulator has concluded that Brexit will not put its patients at risk of losing access to essential drugs while Ireland has drawn up a watch list of some 24 medicines whose supply would be most vulnerable if Britain crashes out without a divorce deal.